Why NuVasive Stock Gained 14% in July

Medical device specialist NuVasive (NASDAQ: NUVA) outpaced the market last month by gaining 14% compared to a 1% uptick in the S&P 500, according to S&P Global Market Intelligence. The rally lifted shares to an over-30% return so far in 2019 compared to 16% growth in the broader market.

Image source: Getty Images.

July's rally was sparked by a late-month quarterly earnings announcement that was well received on Wall Street. In that report, the company announced modestly higher sales that met expectations. Earnings growth was more robust than expected, though, on strength in NuVasive's U.S. market.

Source Fool.com